Skip to content
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Language
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
RATIONALE AND DESIGN OF THE GA...
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Permanent link
RATIONALE AND DESIGN OF THE GASTRANOX TRIAL ON A LOW-MOLECULAR-WEIGHT HEPARIN [LMWH], ENOXAPARIN, WITH CHEMOTHERAPY VS. CHEMOTHERAPY ALONE IN INOPERABLE GASTRIC AND GASTRO-OESOPHAGEAL CANCER
Bibliographic Details
Main Authors:
Kakkar, A
,
Doval, D
,
Fareed, J
,
Kerr, D
,
Maganji, J
,
Mueller, I
Format:
Conference item
Published:
2010
Holdings
Description
Similar Items
Staff View
Similar Items
Heparin‐induced hyperkalemia, can LMWH cause hyperkalemia? A systematic review
by: Gedion Yilma Amdetsion, et al.
Published: (2023-11-01)
Oesophageal and gastro-oesophageal junction tumours
by: Bird-Lieberman, E, et al.
Published: (2007)
Impact on postoperative complications of changes in skeletal muscle mass during neoadjuvant chemotherapy for gastro‐oesophageal cancer
by: den Boer, RB, et al.
Published: (2020)
Controversies of Gastro-oesophageal Junction and “Gastric cardia” and the role of Gastro-oesophageal reflux in it
by: S. Wijetunge
Published: (2022-08-01)
Economic evaluation of FLOT and ECF/ECX perioperative chemotherapy in patients with resectable gastric or gastro-oesophageal junction adenocarcinoma
by: Xiaohui Zeng, et al.
Published: (2022-11-01)